THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

Efficacy of posaconazole for prophylaxis was evaluated in 77 chemotherapy cycles in 59 patients with acute myeloid leukemia (AML) aged 39 (17–62) years from 2012 till 2017. Posaconazole was given in oral suspension 200 mg three times a day after meal during chemotherapy cycle or on 1st day after t...

Full description

Bibliographic Details
Main Authors:	G. A. Klyasova, V. A. Okhmat, E. N. Parovichnikova, E. O. Gribanova, V. V. Troitskaya, V. G. Savchenko
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-11-01
Series:	Медицинский совет
Subjects:	posaconazole antifungal prophylaxis invasive mycoses hematological malignancies acute leukemia aml
Online Access:	https://www.med-sovet.pro/jour/article/view/2176

Similar Items

The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
by: Vildan Özkocaman, et al.
Published: (2018-11-01)

The tablet formulation of posaconazole: clinical pharmacology and the use in patients with hematologic malignancies
by: Veselov A.V.
Published: (2020-05-01)

Evaluation of Posaconazole for Primary Prophylaxis of IFI in Acute Myeloid Leukemia under Intensive Induction Chemotherapy. Comparative Real Life Study with Fluconazole in two Hematological Centers in Algeri
by: Mohamed Amine Bekadja, et al.
Published: (2021-12-01)

Efficacy of Posaconazole Prophylaxis for Fungal Disease in Hematology Patients Treated With Chemotherapy and Transplantation: An Open-Label, Prospective, Observational Study
by: Weiyang Li, et al.
Published: (2020-03-01)

Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
by: Döring Michaela, et al.
Published: (2012-10-01)

Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center
by: Edward T. Van Matre, et al.
Published: (2019-03-01)

Infectious complications in patients with acute leukemia according to the duration of neutropenia
by: V. A. Okhmat, et al.
Published: (2018-10-01)

Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
by: Peipei Ye, et al.
Published: (2022-05-01)

INFECTIONS ON DIFFERENT CHEMOTHERAPY CYCLES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ALL-2009 PROTOCOL
by: V. A. Okhmat, et al.
Published: (2017-10-01)

Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India
by: Parikshit S. Prayag, et al.
Published: (2022-11-01)

Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia
by: Camille Devanlay, et al.
Published: (2015-06-01)

Intravenous posaconazole: key features of clinical pharmacology and practical applications
by: A. V. Veselov, et al.
Published: (2022-04-01)

New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review
by: Veselov A.V.
Published: (2016-11-01)

Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
by: Changcheng Shi, et al.
Published: (2022-05-01)

Antifungal resistance in superficial mycoses
by: Aditya K. Gupta, et al.
Published: (2022-05-01)

Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature
by: Nurhayat Yakut, et al.
Published: (2020-01-01)

Treatment of superficial mycoses: review - part II
by: Maria Fernanda Reis Gavazzoni Dias, et al.
Published: (2013-12-01)

Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These “<i>Magic Bullets</i>”
by: Simona Bernardi, et al.
Published: (2021-02-01)

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia
by: Simona De Gregori, et al.
Published: (2023-06-01)

Scope monograph on human mycoses : a visual outline of the characteristics of the dermatophytes and the deep mycoses, including the taxonomy of the various fungi involved/
by: Beneke, E. S. (Everett Smith), 1918- author, et al.
Published: (1976)

Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole
by: Paulien E. Bunskoek, et al.
Published: (2017-06-01)

Update on therapy for superficial mycoses: review article part I
by: Maria Fernanda Reis Gavazzoni Dias, et al.
Published: (2013-10-01)

Analytical Study on Current Trends in the Clinico-Mycological Profile among Patients with Superficial Mycoses
by: Shreekant Tiwari, et al.
Published: (2023-04-01)

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia
by: Ian M. Bouligny, et al.
Published: (2023-05-01)

Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis
by: Lu Chen, et al.
Published: (2018-04-01)

Human mycoses
by: Tasić Siniša B., et al.
Published: (2005-01-01)

Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
by: Yali Li, et al.
Published: (2022-12-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.
Published: (2013-02-01)

Posaconazole as rescue therapy in African histoplasmosis
by: Daniel Gonçalves, et al.

Deciphering the Relationship Between the Trough Concentration of Posaconazole and Its Efficacy and Safety in Chinese Patients With Hematological Disorders
by: Meng-Meng Jia, et al.
Published: (2020-10-01)

UV Spectrophotometric method for determination of posaconazole: comparison to HPLC
by: Andressa S. Bitencourt, et al.
Published: (2015-10-01)

Acute Myeloid Leukemia (AML) as a model for cancer therapy
by: Farhad eRavandi
Published: (2012-10-01)

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia
by: Alexander J. Ambinder, et al.
Published: (2022-10-01)

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

Invasive Mycoses: Clinical Aspect
by: Neşe SALTOĞLU
Published: (2006-12-01)

Posaconazole-induced Glucocorticoid Deficiency in a Patient with Myelodysplastic syndrome.
by: Antonia Precali, et al.
Published: (2023-01-01)

Superficial and subcutaneous mycoses
by: Gianluigi Lombardi, et al.
Published: (2020-07-01)

Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: A real-world, retrospective comparative single-centre study
by: Bernhard Gerber, et al.
Published: (2014-07-01)

RSK Isoforms in Acute Myeloid Leukemia
by: Minyoung Youn, et al.
Published: (2021-06-01)

A review of treatment options employed in relapsed/refractory AML
by: Mohamed Zakee Mohamed Jiffry, et al.
Published: (2023-12-01)